Entity

Time filter

Source Type


Abate-Daga D.,Institute dinvestigacions Biomediques August Pi i Sunyer IDIBAPS | Andreu N.,Research Center Biomedica En Red Of Enfermedades Raras Ciberer | Camacho-Sanchez J.,IDIBELL Catalan Institute of Oncology ICO | Alemany R.,IDIBELL Catalan Institute of Oncology ICO | And 4 more authors.
PLoS ONE | Year: 2011

Replication-competent adenoviruses armed with thymidine kinase (TK) combine the concepts of virotherapy and suicide gene therapy. Moreover TK-activity can be detected by noninvasive positron emission-computed tomography (PET) imaging, what could potentially facilitate virus monitoring in vivo. Here, we report the generation of a novel oncolytic adenovirus that incorporates the Tat8-TK gene under the control of the Major Late Promoter in a highly selective backbone thus providing selectivity by targeting the retinoblastoma pathway. The selective oncolytic TK virus, termed ICOVIR5-TK-L, showed reduced potency compared to a non-selective counterpart. However the combination of ICOVIR5-TK-L with ganciclovir (GCV) induced a potent antitumoural effect similar to that of wild type adenovirus in a preclinical model of pancreatic cancer. Although the treatment with GCV provoked a reduction in the viral yield, both in vitro and in vivo, a two-cycle treatment of virus and GCV resulted in an enhanced antitumoral response that correlated with high TK-activity, based on microPET measurements. Thus, TK-expressing oncolytic adenoviruses can be traced by PET imaging providing real time information on the activity of the virus and its antitumoral potency can be optimized by GCV dosing. © 2011 Abate-Daga et al.

Discover hidden collaborations